Association of Serum Melatonin Level with Mild Cognitive Impairment in Type 2 Diabetic Patients: A Cross-Sectional Study
Objectives. Melatonin is an essential neuroendocrine hormone that participates in the regulation of sleep rhythm and cognitive function. This study aimed to determine serum melatonin levels with mild cognitive impairment (MCI) in patients with type 2 diabetes (T2DM). Methods. A total of 247 T2DM pat...
Main Authors: | Jichen Zhang, Jiancan Lu, Hongling Zhu, Xinglu Zhou, Xijuan Wei, Mingjun Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/5566019 |
Similar Items
-
RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.
by: Pin Wang, et al.
Published: (2016-01-01) -
A Large, Cross-sectional Observational Study of Serum BDNF, Cognitive Function, and Mild Cognitive Impairment in the Elderly
by: Hiroyuki eShimada, et al.
Published: (2014-04-01) -
Multimodality neuroimaging in mild cognitive impairment: A cross-sectional comparison study
by: R Sheelakumari, et al.
Published: (2018-01-01) -
Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment.
by: Malgorzata Gorska-Ciebiada, et al.
Published: (2015-01-01) -
Mild cognitive impairment in maintenance hemodialysis patients: a cross-sectional survey and cohort study
by: Pei XH, et al.
Published: (2018-12-01)